These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14518256)

  • 1. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
    Musholt PB; Musholt TJ; Moley JF; Scheumann GF
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 3. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
    Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S
    Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
    Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].
    Frilling A; Bockhorn M; Kalinin V; Liedke M; Kaun M; Broelsch CE
    Chirurg; 1997 Aug; 68(8):789-93. PubMed ID: 9377989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.
    Vandenbosch K; Renard M; Uyttebroeck A; Sciot R; Matthijs G; Legius E
    Genet Couns; 2005; 16(1):95-100. PubMed ID: 15844786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
    Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
    Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel mutations in the RET proto-oncogene.
    Kalinin VN; Amosenko FA; Shabanov MA; Lubchenko LN; Hosch SB; Garkavtseva RF; Izbicki JR
    J Mol Med (Berl); 2001 Oct; 79(10):609-12. PubMed ID: 11692159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
    Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma?
    De Miguel M; Fernández-Santos JM; Trigo-Sánchez I; Matera I; Ceccherini I; Martín I; Romeo G; Galera-Davidson H
    Lab Anim; 2003 Jul; 37(3):215-21. PubMed ID: 12869284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
    Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
    Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
    [No Abstract]   [Full Text] [Related]  

  • 13. Does phaster mean better?
    Angrist M
    Clin Chem; 1997 Mar; 43(3):424-6. PubMed ID: 9068584
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
    Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
    [No Abstract]   [Full Text] [Related]  

  • 15. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
    Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
    Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
    [No Abstract]   [Full Text] [Related]  

  • 16. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
    Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
    Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
    Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
    Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.